Joanna Szczepanik - Concepedia

Author

Joanna Szczepanik

National Institutes of Health

Also Known As

J Szczepanik, J. Szczepanik, Joanna E. Szczepanik, Joanna Szczepanik, SZCZEPANIK, JOANNA

Publications

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health National Institute of Mental Health Janssen (United States)Johnson & Johnson (United States)Laureate Institute for Brain Research

About

Joanna Szczepanik is an author at National Institutes of Health specializing in social sciences, medicine, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Social Sciences	8	8	378
2	Medicine	7	7	379
3	Behavioral Sciences	2	2	34
4	Cognitive Science	2	2	31
5	Immunology	1	1	74

Joanna Szczepanik

Publications

Citations

H-Index

Page 1

	Year	Citations
Interactive Effects of Age and Hypertension on Volumes of Brain Structures Terri L. Strassburger, Hing-Chung Lee, Eileen Daly, Stroke	1997	194
Default Mode Connectivity in Major Depressive Disorder Measured Up to 10 Days After Ketamine Administration Jennifer W. Evans, Joanna Szczepanik, Nancy E. Brutsché, Biological Psychiatry PsychiatryMood SymptomSubcortical Ischemic DepressionKetamine AdministrationDepression	2018	157
Lateralization and gender differences in the dopaminergic response to unpredictable reward in the human ventral striatum Chantal Martin‐Soelch, Joanna Szczepanik, Allison C. Nugent, European Journal of Neuroscience	2011	83
DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorder Jonathan Savitz, Colin A. Hodgkinson, Chantal Martin‐Soelch, The International Journal of Neuropsychopharmacology D2/3 ReceptorImmunologyPsychopharmacologySocial SciencesReward-associated Dopamine Release	2013	74
The Functional DRD3 Ser9Gly Polymorphism (rs6280) Is Pleiotropic, Affecting Reward as Well as Movement Jonathan Savitz, Colin A. Hodgkinson, Chantal Martin‐Soelch, PLoS ONE	2013	70
Ketamine normalizes brain activity during emotionally valenced attentional processing in depression Jessica Reed, Allison C. Nugent, Maura L. Furey, NeuroImage Clinical	2018	66
Effects of Ketamine on Brain Activity During Emotional Processing: Differential Findings in Depressed Versus Healthy Control Participants Jessica Reed, Allison C. Nugent, Maura L. Furey, Biological Psychiatry Cognitive Neuroscience and Neuroimaging Differential FindingsPsychiatryNeurophysiologyPsychotropic MedicationNeurobiological Factor	2019	58
Relation of age and apolipoprotein E to cognitive function in Down syndrome adults Gene E. Alexander, Ann M. Saunders, Joanna Szczepanik, Neuroreport	1997	41
Neurophysiological Changes Associated with Antidepressant Response to Ketamine Not Observed in a Negative Trial of Scopolamine in Major Depressive Disorder Lawrence Park, Maura Furey, Allison C. Nugent, The International Journal of Neuropsychopharmacology	2018	35
Time Course of Pharmacodynamic and Pharmacokinetic Effects of Physostigmine Assessed by Functional Brain Imaging in Humans Maura L. Furey, Pietro Pietrini, Gene E. Alexander, Pharmacology Biochemistry and Behavior Neuroimaging BiomarkersPharmacokinetic EffectsNeuroimaging ModalityNeurophysiological BiomarkersNeuropharmacology	2000	32

Page 1